Company Profile
Mirzyme Therapeutics Limited
10133310•Private Limited With Share Capital
Get Full Access
19/04/2016
10 years
4
6
72110
low risk
Company Overview
Registration, classification & business activity
Mirzyme Therapeutics Limited (10133310) is a private limited with share capital incorporated on 19/04/2016 (10 years old) and registered in birmingham, B74BB. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Mirzyme therapeutics is an innovative biopharmaceutical company that focuses on the development and commercialisation of diagnostics and drugs for women with pregnancy complications, specifically preeclampsia
Financial Overview
£843.3K
£147.2K
£696.1K
£2.53M
£314.1K
Key Metrics
6
Employees
4
Directors
4
Shareholders
2
Patents
Board of Directors
Innovate Grants
This company received a grant of £443742.19 for Preclinical Development Of The First Orally-Active Substance For The Treatment Of Preeclampsia. The project started on 01/11/2023 and ended on 28/02/2025.
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating